soul trial oral semaglutide cardiovascular outcomes results 2025 (Semaglutide triaL) in individuals with Trial Scorecard: SOUL
Description
Methods Data sources Eligible publications were identified through electronic searches across several databases, including Wanfang, CNKI, Chinese Biomedical Literature, VIP, Embase, PubMed, Cochrane Library, Web of Science from their inception to December 2023
By influencing appetite, metabolism, and fat utilization, these compounds offer a new approach for sustainable weight management
Tirzepatide: A Side-by-Side Comparison Both semaglutide and tirzepatide are effective at aiding weight loss and improving specific metabolic markers
The two things arent mutually exclusive
So much weight loss
